Description

n-[2-(5-Methoxy-1H-Indol-3-Yl)Ethyl]-3-(4-Oxo-1,2,3-Benzotriazin-3(4H)-Yl)Propanamide is a sophisticated synthetic organic compound that combines indole and benzotriazinone pharmacophores, making it a valuable intermediate for advanced research and development. This compound is of significant interest for its potential role in modulating specific biological pathways. It is primarily utilized by pharmaceutical R&D teams and fine chemical manufacturers focused on developing novel therapeutic agents and high-value specialty chemicals.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders.
• Biochemical Research: Used as a reference standard or probe compound in pharmacological and enzymatic studies to investigate receptor-ligand interactions.
• Organic Synthesis: Acts as a versatile precursor for the development of more complex heterocyclic compounds with potential biological activity.
• Academic Research: Employed in university and institutional labs for methodological development and structure-activity relationship (SAR) studies.
• Contract Research Organizations (CROs): Supplied to CROs for client-sponsored discovery programs requiring specialized chemical entities.

Basic Information

Product Name	n-[2-(5-Methoxy-1H-Indol-3-Yl)Ethyl]-3-(4-Oxo-1,2,3-Benzotriazin-3(4H)-Yl)Propanamide
CAS No.	921119-69-9
Molecular Formula	C21H20N6O3
Molecular Weight	404.43 g/mol
Synonyms	3-(4-Oxo-3,4-dihydro-1,2,3-benzotriazin-3-yl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propanamide; Propanamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)-; 921119-69-9; 3-(4-Oxo-3,4-dihydrobenzo[1,2,3]triazin-3-yl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propanamide
EINECS	Contact for details

Quality Control

Our n-[2-(5-Methoxy-1H-Indol-3-Yl)Ethyl]-3-(4-Oxo-1,2,3-Benzotriazin-3(4H)-Yl)Propanamide is produced under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We adhere to cGMP guidelines for the manufacture of pharmaceutical intermediates, ensuring traceability and documentation suitable for regulatory submissions.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. Long-term storage under inert atmosphere (e.g., nitrogen or argon) is recommended for optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.